1031 Doctor™: 1031 Exchange Review, Due Diligence & Brokerage services since 1986
Congratulations — you’ve discovered 1031 Doctor™, an AI supported platform tailored to assist investors with their 1031 exchange inspection and due diligence process, significantly reducing risk in unfamiliar markets. As a former Senior Broker with Marcus & Millichap, one of the largest commercial brokerage firms in the nation, I bring over forty years of experience, and more the one Billion in investment property transactions to your side of the closing table.
You’ve worked hard, invested wisely, and built real estate wealth alongside a demanding professional career. Now you’re preparing to sell, exchange up, or you’ve already sold and are racing through your 45‑day identification window. Suddenly you’re staring at an avalanche of NNN (Single‑Tenant Net‑Leased) opportunities from brokers nationwide — each one promising “stable cash flow” and “zero landlord responsibilities" Now you can get a professional second opinion on that NNN investment for $299.00 within 24 hours.
After decades in the trenches, I’ve watched countless investors rush into NNN deals believing they were buying “stable, passive income,” only to discover hidden risks buried in the lease, the location, or the tenant’s financials, and, without the time or expertise to properly vet each deal, even a well‑intentioned investment can turn into a long‑term liability.
Don’t pull the trigger on that LoopNet or CREXI listing until you’ve fully reviewed and diagnosed it from head to toe with 1031 Doctor™. Listings are polished, pro formas are optimistic, and brokers are experts at making every property look like a “can’t‑miss” opportunity. But before you commit your exchange dollars, you need a seasoned professional who knows exactly how to read the vital signs and make the correct diagnoses.
Get your NNN investment professionally reviewed today!
1031 Doctor™ provides real estate brokerage, site evaluations and 1031 exchange advisory services and does not give legal or tax advice.